Beijing Tongren Hospital,Capital Medical University

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efficacy and Safety of Taitacept in Treatment of Refractory or Recurrent Anti-NMDAR/anti-LGI1 Encephalitis	Neoplasms by Site, Neuroinflammatory Diseases, Paraneoplastic Syndromes, Nervous System, anti-NMDA receptor encephalitis, autoimmune disease, autoimmune disorder of the nervous system, brain disorder, central nervous system disorder, encephalitis, immune system disorder, neoplasm, nervous system disorder, neurodegenerative disease, paraneoplastic syndrome	Recruiting	Phase 2	2024-11-20		NCT06510283

Clinical trials